$205 Million

Berkeley Lights

Initial Public Offering

Bookrunner, July 2020

Berkeley Lights, Inc. is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. This is a new way to capture and interpret the qualitative language of biology and translate it into single-cell specific digital information, referred to as Digital Cell Biology. The Company currently focuses on enabling the large and rapidly growing markets of antibody therapeutics, cell therapy and synthetic biology with its platform. The Company’s goal is to establish the Berkeley Lights Platform as the standard throughout the cell-based product value chain by increasing the probability of successful product development for its customers.

More Like This

Nov 2020
$240 Million

Initial Public Offering

Bookrunner

View Details
Oct 2020
$135 Million

Initial Public Offering

Bookrunner

View Details
Oct 2020
$219 Million

Initial Public Offering

Lead Left Bookrunner

View Details